EFFECT OF ENDOGENOUS CHOLECYSTOKININ ON POSTPRANDIAL GALLBLADDER - REFILLING ULTRASONOGRAPHIC STUDY IN HEALTHY-SUBJECTS AND IN GALLSTONE PATIENTS

被引:8
作者
CICALA, M
CORAZZIARI, E
DIACINTI, D
BADIALI, D
TORSOLI, A
机构
[1] UNIV ROMA LA SAPIENZA,MED CLIN 2,CATTEDRA GASTROENTEROL 1,I-00161 ROME,ITALY
[2] UNIV ROMA LA SAPIENZA,MED CLIN 2,SERV RADIOL,I-00161 ROME,ITALY
关键词
CHOLECYSTOKININ ANTAGONISTS; GALLBLADDER MOTILITY; GALLSTONES;
D O I
10.1007/BF02063946
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The postprandial release of cholecystokinin (CCK) regulates gallbladder (GB) contraction but little is known about the role, if any, of the still-elevated CCK blood levels on subsequent GB refilling. To assess the role of CCK in GB refilling, a CCK-receptor antagonist, loxiglumide, or saline were infused intravenously in a random double-blind fashion after the ingestion of a liquid test meal in 16 healthy subjects. An identical study protocol was performed in 10 GB ''contractor'' patients with radiolucent stones to ascertain whether the reported reduced CCK effect on GB emptying also affects GB refilling. GB volumes were assessed ultrasonographically in the fasting state and for 150 min at 15-min intervals after meal ingestion. GB volumes during postprandial refilling were significantly greater during loxiglumide than placebo infusion (P < 0.01), but they did not differ between gallstone and control subjects. In conclusion, postprandial endogenous CCK has a relevant role in delaying GB refilling, and this effect is not altered in patients with radiolucent gallstones.
引用
收藏
页码:76 / 81
页数:6
相关论文
共 28 条
[11]   EFFECT OF GRADED PHYSIOLOGIC DOSES OF CHOLECYSTOKININ ON GALLBLADDER CONTRACTION MEASURED BY ULTRASONOGRAPHY - DETERMINATION OF THRESHOLD, DOSE-RESPONSE RELATIONSHIPS AND COMPARISON WITH INTRADUODENAL BILIRUBIN OUTPUT [J].
HOPMAN, WPM ;
KERSTENS, PJSM ;
JANSEN, JBMJ ;
ROSENBUSCH, G ;
LAMERS, CBHW .
GASTROENTEROLOGY, 1985, 89 (06) :1242-1247
[12]   RADIOIMMUNOASSAY OF CHOLECYSTOKININ IN HUMAN-TISSUE AND PLASMA [J].
JANSEN, JBMJ ;
LAMERS, CBHW .
CLINICA CHIMICA ACTA, 1983, 131 (03) :305-316
[13]  
JENSEN RT, 1991, CHOLECYSTOKININ ANTA, P93
[14]  
LAWSON M, 1983, GASTROENTEROLOGY, V85, P866
[15]   REGULATION OF PANCREATIC ENDOCRINE FUNCTION BY CHOLECYSTOKININ - STUDIES WITH MK-329, A NONPEPTIDE CHOLECYSTOKININ RECEPTOR ANTAGONIST [J].
LIDDLE, RA ;
GERTZ, BJ ;
KANAYAMA, S ;
BECCARIA, L ;
GETTYS, TW ;
TAYLOR, IL ;
RUSHAKOFF, RJ ;
WILLIAMS, VC ;
COKER, LD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (05) :1312-1318
[16]  
LIDDLE RA, 1984, GASTROENTEROLOGY, V87, P842
[17]  
LILJA P, 1982, GASTROENTEROLOGY, V83, P256
[18]   PLASMA CHOLECYSTOKININ AND GALLBLADDER RESPONSES TO INTRADUODENAL FAT IN GALLSTONE PATIENTS [J].
MASCLEE, AAM ;
JANSEN, JBMJ ;
DRIESSEN, WMM ;
GEUSKENS, LM ;
LAMERS, CBHW .
DIGESTIVE DISEASES AND SCIENCES, 1989, 34 (03) :353-359
[19]   INFUSION OF CHOLECYSTOKININ OCTAPEPTIDE IN MAN - RELATION BETWEEN PLASMA CHOLECYSTOKININ CONCENTRATIONS AND GALLBLADDER EMPTYING RATES [J].
MATON, PN ;
SELDEN, AC ;
FITZPATRICK, ML ;
CHADWICK, VS .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1984, 14 (01) :37-41
[20]   EFFECT OF LOXIGLUMIDE, A CHOLECYSTOKININ ANTAGONIST, ON PANCREATIC-POLYPEPTIDE RELEASE IN HUMANS [J].
MEIER, R ;
HILDEBRAND, P ;
THUMSHIRN, M ;
ALBRECHT, C ;
STUDER, B ;
GYR, K ;
BEGLINGER, C .
GASTROENTEROLOGY, 1990, 99 (06) :1757-1762